- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05642416
Intermittent Bolus vs Continuous Infusion Via ESP Catheters RCT
April 3, 2024 updated by: Patrick Forrest, Henry Ford Health System
Intermittent Bolus Versus Continuous Infusion Erector Spinae Catheters for Median Sternotomy Incisions: A Prospective Randomized Controlled Trial
The purpose of this prospective randomized controlled trial is to compare the effectiveness of two different delivery methods for postoperative pain management following cardiac surgery requiring median sternotomy: intermittent programmed LA bolus versus continuous LA infusion through ESP catheters.
Effectiveness of analgesia will be assessed based on the subjects' NRS pain scores and opioid consumption.
The primary outcome measure will be the patients' opioid consumption over the course of the 72 hours following surgery.
Secondary outcomes measures that will be evaluated include NRS pain scores, intensive care unit (ICU) length of stay, and time to first dose of antiemetic in the postoperative period.
It is hypothesized that the use of intermittent programmed LA boluses will provide better analgesia compared to continuous LA infusion through ESP catheters.
The findings of this study will provide guidance regarding the optimal method of delivery for postoperative pain management in patients following cardiac surgery.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The purpose of this prospective randomized controlled trial is to compare the effectiveness of two different delivery methods for postoperative pain management following cardiac surgery requiring median sternotomy: intermittent programmed LA bolus versus continuous LA infusion through ESP catheters.
Effectiveness of analgesia will be assessed based on the subjects' NRS pain scores and opioid consumption.
The primary outcome measure will be the patients' opioid consumption over the course of the 72 hours following surgery.
Secondary outcomes measures that will be evaluated include NRS pain scores, intensive care unit (ICU) length of stay, and time to first dose of antiemetic in the postoperative period.
It is hypothesized that the use of intermittent programmed LA boluses will provide better analgesia compared to continuous LA infusion through ESP catheters.
The findings of this study will provide guidance regarding the optimal method of delivery for postoperative pain management in patients following cardiac surgery.
Study Type
Interventional
Enrollment (Estimated)
240
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Katherine Nowak, PhD
- Phone Number: 313-771-7128
- Email: knowak2@hfhs.org
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Recruiting
- Henry Ford Hospital
-
Contact:
- Katherine Nowak, PhD
- Phone Number: 313-771-7128
- Email: knowak2@hfhs.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Non-emergent elective cardiac surgery requiring median sternotomy for surgical exposure (i.e. CABG, aortic/mitral/tricuspid valve replacements) receiving ESP catheter preoperatively
- Age 18-90
Exclusion Criteria:
- Placement and/or existence of cardiac assist devices (LVAD, RVAD, Balloon Pump, Impella)
- Neurocognitive dysfunction
- Patients who expire before extubation
- Non-English speaking
- Daily opioid therapy prior to surgery
- History of substance abuse
- BMI > 45
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Continuous Infusion
Will receive a continuous infusion of pain medication (0.2% ropivacaine at a rate of 10mL per hour- 5mL per side per hour) via erector spinae plane (ESP) catheter for their postoperative pain following median sternotomy incision.
|
Continuous infusion of ropivacaine
|
Experimental: Intermittent Bolus
Will receive intermittent boluses of pain medication (30mL bolus of 0.2% ropivacaine every three hours) via erector spinae plane (ESP) catheter for their postoperative pain following median sternotomy incision.
|
Intermittent bolus of ropivacaine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Opioid consumption
Time Frame: 72 hours post-op
|
Opioid consumption (MME) over the course of the 72 hours following surgery
|
72 hours post-op
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
NRS Pain Scores (10)
Time Frame: 72 post-op
|
Numeric rating scale for pain (rated 0=no pain through 10= worst imaginable pain)
|
72 post-op
|
ICU length of stay
Time Frame: 72 hours post-op
|
Time from post-op to step-down from ICU
|
72 hours post-op
|
Quality of Recovery 15 (QoR-15) score
Time Frame: 72 hours post-op
|
Quality of Recovery 15 (QoR-15) score: 15 question survey (0=very poor recovery through 150=excellent recovery)
|
72 hours post-op
|
Time to first antiemetic
Time Frame: 72 hours post-op
|
Time to first antiemetic
|
72 hours post-op
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 15, 2022
Primary Completion (Estimated)
November 30, 2024
Study Completion (Estimated)
November 30, 2024
Study Registration Dates
First Submitted
November 30, 2022
First Submitted That Met QC Criteria
November 30, 2022
First Posted (Actual)
December 8, 2022
Study Record Updates
Last Update Posted (Actual)
April 4, 2024
Last Update Submitted That Met QC Criteria
April 3, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15737
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
We will not make individual participant data available to other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Operative Pain
-
Kaohsiung Medical University Chung-Ho Memorial...Not yet recruitingPostoperative Complications | Chronic Post Operative Pain | Acute Post Operative PainTaiwan
-
MercyOne Des Moines Medical CenterTerminatedPost Operative Pain | Post Operative Nausea and VomitingUnited States
-
Assiut UniversityRecruitingPost Operative PainEgypt
-
Ahmed M Maged, MDNot yet recruiting
-
Pakistan Institute of Medical SciencesRecruiting
-
National Trauma CenterNot yet recruiting
-
Armed Forces Institute of Dentistry, PakistanRecruitingPost Operative PainPakistan
-
National Cancer Institute, EgyptRecruitingPost Operative PainEgypt
-
British University In EgyptRecruitingPost Operative PainEgypt
-
Kasr El Aini HospitalRecruiting
Clinical Trials on Continuous Infusion of ropivacaine
-
University Health Network, TorontoUnknownPIB Versus CI Through a Popliteal Sciatic Nerve Catheter for Analgesia Following Major Ankle SurgeryPain, PostoperativeCanada
-
University Hospital, RouenCompleted
-
Mayo ClinicCompletedOsteoarthritis, KneeUnited States
-
University of California, San DiegoEnrolling by invitationTrauma Injury | Pain, Acute PostoperativeUnited States
-
ASST Gaetano Pini-CTOCompletedInjury of Anterior Cruciate LigamentItaly
-
Stanford UniversityCompletedPain, Postoperative | Surgical Procedure, UnspecifiedUnited States
-
Mongi Slim HospitalCompletedEpidural; AnalgesiaTunisia
-
Cui XuleiCompletedAnalgesia | Hepatectomy | Nerve BlockChina
-
TriHealth Inc.WithdrawnPain, Postoperative | Shoulder OsteoarthritisUnited States
-
Northwell HealthCompleted